复制人类糖尿病:从一种新的动物模型的见解
Silvia Teixidó-Trujillo1,2, Esteban Porrini3,2, Luis Manuel Menéndez-Quintanal4
1Faculty of Medicine, Universidad de La Laguna, San Cristóbal de la Laguna, Spain.
American journal of physiology. Endocrinology and metabolism
|September 12, 2025
概括
一种针对2型糖尿病的新型临床前模型将高脂肪饮食与大鼠的塔克罗利斯 (TAC) 治疗结合起来. 这种模型表现出高血糖,小岛损伤和细胞比例的改变,为糖尿病研究提供了更好的工具.
科学领域:
- 内分泌学和新陈代谢学
- 临床前研究模型 临床前研究模型
- 糖尿病病理生理学 糖尿病病理生理学
背景情况:
- 2型糖尿病是一种全球流行病,具有复杂,多因素的发病因子.
- 目前的动物模型无法充分复制2型糖尿病的病理生理学和相关的器官损伤.
- 了解β细胞功能障碍对于预防和治疗糖尿病至关重要,但仍然不清楚.
研究的目的:
- 开发一种新的,非基因型的2型糖尿病临床前模型.
- 调查结合肥胖和塔克罗利斯 (TAC) 治疗对糖尿病发展的影响.
- 为研究糖尿病病理生理学和器官损伤提供一个更合适的模型.
主要方法:
- 斯普拉格-道利雄性大鼠被食高脂肪 (HF) 饮食以诱导肥胖和代谢综合征.
- 作为一种免疫抑制剂的塔克罗利斯 (TAC) 药物被用了6-9个月以诱发慢性高血糖症.
- 评估胰腺变化,包括小岛形态,细胞组成,胰岛素/葡萄糖含量和关键转录因子表达.
主要成果:
- 接受TAC治疗的肥胖大鼠患有慢性高血糖症和葡萄糖耐受性受损.
- 兰格汉斯小岛面积和数量显著减少,有岛屿纤维化的证据.
- 降低了胰岛素含量,改变了α/β细胞比率,降低了MAFA,FOXO1A,PDX-1和NEUROD1.1的表达.
结论:
- 这种HF饮食和TAC诱导模型为2型糖尿病提供了更相关的临床前表现.
- 该模型展示了关键的病理特征,包括高血糖症,小岛功能障碍和纤维化.
- 它为调查糖尿病病原和治疗干预提供了宝贵的工具.
相关概念视频
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:26Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28